THE HEART IN RHEUMATOID ARTHRITIS ? AN ECHOCARDIOGRAPHIC STUDY.
Journal Title: International Journal of Advanced Research (IJAR) - Year 2018, Vol 6, Issue 10
Abstract
Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease of the joints. Joint pain, swelling and limited mobility of the joint are the most prominent features. Besides articular symptoms, RA can be associated with extra-articular features. Among those extra-articular features are cardiovascular diseases, including pericarditis, cardiomyopathy/ myocarditis, cardiac amyloidosis, coronary vasculitis, arrythmia, valve diseases and, most importantly, congestive heart failure and ischaemic heart disease. When compared with the general population, RA is associated with an increased mortality, the majority of which is originating from cardiovascular diseases. Objectives: To study cardiac manifestations in patients of rheumatoid arthritis by echocardiography with the objective of providing elements for earlier diagnosis and treatment. Material and Methods: The study was conducted in the Postgraduate Department of Medicine at S.M.H.S Hospital obtaining ethical clearance from the institutional ethical committee. The study was conducted from April 2016 to September 2017. A Total of 110 patients of RA attending Rheumatology OPD in SMHS Hospital in Srinagar, were taken into this study after obtaining informed consent. All patients were either previously or newly diagnosed cases of rheumatoid arthritis. New cases were investigated in the form of ESR, CRP, RF, ANTI-CCP for the diagnosis of RA as per ACR EULAR (2010) criteria. All those who met the ACR EULAR (2010) criteria for RA were screened for cardiac manifestations. Patients were examined clinically for cardiac signs and symptoms and patients were evaluated for cardiac manifestations by echocardiography. Results: Out of 110 studied patients 49% had heart involvement. Mitral regurgitation was the most common heart disease present in 20% of patients, followed by aortic regurgitation in 15.5% of patients, diastolic dysfunction in 14.5% of patients, tricuspid regurgitation in 11.8% of patients, PAH in 10.9% of patients, pericardial effusion in 9.1% of patients, systolic dysfunction in 6.3% of patients, cardiomyopathy (DCM) in 4.5% of patients, ischemic heart disease in 4.5% of patients, mitral stenosis in 0.9% and aortic stenosis in 0.9% of patients. The mean age at detection of heart disease in RA was 53 ?10.65 years, higher than mean age of studied RA patients (49.8?11.5). Analysing the pattern of distribution of age in RA patients with and without heart involvement, the heart involvement increased proportionately as the age advanced. Duration of illness in our study had a marked impact over the progression of heart involvement in patients of RA. Number of patients with heart disease increases with increase in duration of illness. Study showed that 9 (27.3%) patients had disease duration of ≤ 5 years, 23 (46.9%) patients had disease duration of 6-10 years, 16 (76.2%) patients had disease duration of 11-15 years, and 6 (85.7%) patients had disease duration of > 15 years of illness, with a statistically significant P value of P = 0.001 . Though females outnumbered males by a ratio of 3.6:1 as is characteristic of autoimmune disorder, once gender comparison of RA patients was done (Among these 110 patients, 24 (22%) subjects were male and 86 (78 %) subjects were female) there was no significant relation between gender and abnormal echocardiography findings in RA patients (p > 0.05). It was also observed in our study that RA patients with positive CRP mg/L (p =0.02), higher levels of RF IU/ml (p = 0.03) and higher levels of anti-CCP U/ml (P=0.01) were affected more than patients who had negative CRP mg/l, lower levels of RF IU/ml and anti-CCP U/ml. Conclusion: An observational study conducted to see cardiac involvement in patients of rheumatoid arthritis showed that 49% had cardiac involvement. Mitral regurgitation was the most common heart disease present in 20% of patients, followed by aortic regurgitation in 15.5% of patients, diastolic dysfunction in 14.5% of patients, tricuspid regurgitation in 11.8% of patients, PAH in 10.9% of patients, pericardial effusion in 9.1% of patients, systolic dysfunction in 6.3% of patients, cardiomyopathy (DCM) in 4.5% of patients, ischemic heart disease in 4.5% of patients, mitral stenosis in 0.9% and aortic stenosis in 0.9% of patients.
Authors and Affiliations
Owais Ahmed Wani, Abdul Khaliq, syedManzoor Ali Andrabi, ShahoodAjaz Kakroo, Sobia Nisar, Manzoor Teli.
Keywords
Related Articles
- EP ID EP409982
- DOI 10.21474/IJAR01/7899
- Views 55
- Downloads 0
THROMBIN ENHANCES OVALBUMIN-SPECIFIC IGA IN MUCOSAL SURFACES BY INTRANASAL ADMINISTRATION IN MICE.
Thrombin plays a central role in blood coagulation. In addition, thrombin is an important inflammatory mediator that activates T lymphocytes and monocytes and induces the release of proinflammatory cytokines in vitro. Ho...
ASSESSMENT OF READINESS TO HANDLE FIRE CHALLENGES IN A TERTIARY CARE TEACHING INSTITUTE.
Rationale:Fire incidents in hospitals in the recent past have brought to fore the necessity of continuous efforts for fire prevention in all Healthcare organizations (HCOs). The recent devastating fire accidents in count...
ENHANCING THE EXISTING COFFEE GENETIC RESOURCES IN NIGERIA THROUGH IN VITRO CULTURE CONSERVATION.
This study aimed at enhancing and conserving existing coffee genetic resources in Nigeria through in vitro culture. In Nigeria there is an urgent need for proper maintenance of coffee genetic materials. This will pave wa...
THE LONG-RUN RELATIONSHIP BETWEEN OUTPUT, MONEY, AND PRICES: EMPIRICAL EVIDENCE FROM SYRIA.
The aim of this study is to examine the long-run relationship between nominal GDP, money supply and inflation rate in Syria over the period 1980-2012. Using annual data, the Johansen Co-integration analysis was applied i...
RADIATION SHIELDING PROPERTIES OF BORIDED FE-NI ALLOYS.
In this study, the radiation shielding properties of borided Fe-Ni binary alloys (Ni 60 wt.% and Ni-80 wt.%) have been investigated. For this purpose, linear attenuation coefficients at photon energy levels of 662 keV, 1...